New Jersey bill wants one prior auth form for every drug insurer

The bill is two sentences long - and it has been tried before
New Jersey bill wants one prior auth form for every drug insurer
RISK, COMPLIANCE & LEGAL
By Regielyn Santiago
Nov 20, 2026

What happened: A New Jersey bill would require every health insurer in the state to accept one standard form for prescription drug prior authorizations. 

Who’s involved: New Jersey’s Department of Banking and Insurance, health insurers, pharmacy benefit managers, and network providers. 

What’s at stake: A mandated single form for all prescription drug prior auth requests - paper and electronic. 

Why it matters: Payers would lose the ability to set their own prior auth form requirements for drug coverage. 

Where it stands: Introduced November 16, 2026; no committee action yet. 

 

The New Jersey lawmaker behind the state’s landmark prior authorization overhaul is back with unfinished business. 

Assemblyman Sterley S. Stanley - the same sponsor behind the Ensuring Transparency in Prior Authorization Act, signed into law in January 2024 - introduced Assembly Bill 5783 on November 16, 2026. The bill would require the Commissioner of Banking and Insurance to develop one standard prior authorization request form for prescription drug benefits, to be used by every network provider in the state. 

Every payer would have to make the form available and accept it - in both paper and electronic formats. 

The same form, every insurer 

The bill is two operative sentences. It supplements New Jersey’s existing utilization review framework under P.L.2005, c.352 (C.17B:30-48 et al.), and it would take effect immediately upon enactment. 

Under the proposal, all network providers would submit prescription drug prior auth requests using the state-designed form. Payers - including insurers and pharmacy benefit managers - would have no discretion over the form’s design or format. 

Currently, prior authorization forms and submission requirements vary from payer to payer. Providers navigate different forms and different portals depending on who covers the patient. A5783 would replace that patchwork with a single state-mandated document. 

The bill does not change how prior authorization decisions are made. Insurers would still determine whether to approve or deny a request. What changes is the submission process itself. 

Not the first attempt 

This is not a new idea. An identical bill - A2492 - was introduced in the 2024-2025 legislative session but did not advance. A Senate companion, S2892, carries the same language in the current session. 

The reintroduction comes as New Jersey continues to build on its 2024 prior auth reforms. The ETPAA, which took effect January 1, 2025, set mandated turnaround times for prior auth decisions and required payers to disclose their prior auth requirements publicly. A5783 picks up where that law left off, targeting the submission side of the process rather than the decision timeline. 

Where it goes from here 

A5783 has been introduced but has not been referred to committee. It would need to pass both chambers and be signed by the governor to take effect. 

For health insurers and PBMs operating in New Jersey, the question is whether the state’s next move on prior auth reform will reach their intake systems and form requirements for prescription drug coverage. 

This article covers proposed legislation. A5783 has been introduced but has not been enacted or tested in committee. Its provisions would take effect only if passed and signed into law. 

Related Stories
Free newsletter

We'll keep you up-to-date with the latest breaking news, cutting edge opinion, and expert analysis affecting both your business and the industry as whole.

Free newsletter

Our daily newsletter is FREE and keeps you up - to - date with the world of Insurance. Please complete the form below and click on subscribe for daily newsletters from IB US.